These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34118560)

  • 1. Large-scale evaluation of the Positive and Negative Syndrome Scale (PANSS) symptom architecture in schizophrenia.
    Lim K; Peh OH; Yang Z; Rekhi G; Rapisarda A; See YM; Rashid NAA; Ang MS; Lee SA; Sim K; Huang H; Lencz T; Lee J; Lam M
    Asian J Psychiatr; 2021 Aug; 62():102732. PubMed ID: 34118560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor structure of the positive and negative syndrome scale (PANSS) in people at ultra high risk (UHR) for psychosis.
    Yang Z; Lim K; Lam M; Keefe R; Lee J
    Schizophr Res; 2018 Nov; 201():85-90. PubMed ID: 29804925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptom structure and severity: a comparison of responses to the positive and negative syndrome scale (PANSS) between patients with PTSD or schizophrenia.
    Stefanovics EA; Krystal JH; Rosenheck RA
    Compr Psychiatry; 2014 May; 55(4):887-95. PubMed ID: 24602497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G; Noisette C; Legrand A; Delahousse J
    Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline social amotivation predicts 1-year functioning in UHR subjects: A validation and prospective investigation.
    Lam M; Abdul Rashid NA; Lee SA; Lim J; Foussias G; Fervaha G; Ruhrman S; Remington G; Lee J
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2187-96. PubMed ID: 26553972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of the positive and Negative Syndrome Scale (PANSS) factor structure.
    Shafer A; Dazzi F
    J Psychiatr Res; 2019 Aug; 115():113-120. PubMed ID: 31128501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Converting scores between the PANSS and SAPS/SANS beyond the positive/negative dichotomy.
    Grot S; Giguère CÉ; Smine S; Mongeau-Pérusse V; Nguyen DD; Preda A; Potvin S; van Erp TGM; Fbirn ; Orban P
    Psychiatry Res; 2021 Nov; 305():114199. PubMed ID: 34536695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of the Negative Symptom Assessment-16 in individuals with schizophrenia.
    Rekhi G; Alphs L; Ang MS; Lee J
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1433-1441. PubMed ID: 31761524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validated five-factor model of positive and negative syndrome scale for schizophrenia in Chinese population.
    Jiang J; Sim K; Lee J
    Schizophr Res; 2013 Jan; 143(1):38-43. PubMed ID: 23148897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, behavioural and neural validation of the PANSS amotivation factor.
    Kaliuzhna M; Kirschner M; Carruzzo F; Hartmann-Riemer MN; Bischof M; Seifritz E; Tobler PN; Kaiser S
    Schizophr Res; 2020 Jun; 220():38-45. PubMed ID: 32349887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric and clinical evaluation of schizophrenia remission criteria in outpatients with psychotic disorders.
    Sakinyte K; Holmberg C
    BMC Psychiatry; 2023 Mar; 23(1):207. PubMed ID: 36978160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia.
    Xu K; Krystal JH; Ning Y; Chen DC; He H; Wang D; Ke X; Zhang X; Ding Y; Liu Y; Gueorguieva R; Wang Z; Limoncelli D; Pietrzak RH; Petrakis IL; Zhang X; Fan N
    J Psychiatr Res; 2015 Feb; 61():64-72. PubMed ID: 25560772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can the Positive and Negative Syndrome scale (PANSS) differentiate treatment-resistant from non-treatment-resistant schizophrenia? A factor analytic investigation based on data from the Pattern cohort study.
    Freitas R; Dos Santos B; Altamura C; Bernasconi C; Corral R; Evans J; Malla A; Krebs MO; Nordstroem AL; Zink M; Haro JM; Elkis H
    Psychiatry Res; 2019 Jun; 276():210-217. PubMed ID: 31108345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the factor structure of symptoms in patients with schizophrenia.
    Kim JH; Kim SY; Lee J; Oh KJ; Kim YB; Cho ZH
    Psychiatry Res; 2012 May; 197(3):285-9. PubMed ID: 22364933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis.
    Emsley R; Rabinowitz J; Torreman M;
    Schizophr Res; 2003 May; 61(1):47-57. PubMed ID: 12648735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Validity and Sensitivity of PANSS-6 in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Study.
    Østergaard SD; Foldager L; Mors O; Bech P; Correll CU
    Schizophr Bull; 2018 Feb; 44(2):453-462. PubMed ID: 28575321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and reliability of the French-language version of the Positive and Negative Syndrome Scale (PANSS).
    Lançon C; Reine G; Llorca PM; Auquier P
    Acta Psychiatr Scand; 1999 Sep; 100(3):237-43. PubMed ID: 10493091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
    Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
    Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformed PANSS Factors Intended to Reduce Pseudospecificity Among Symptom Domains and Enhance Understanding of Symptom Change in Antipsychotic-Treated Patients With Schizophrenia.
    Hopkins SC; Ogirala A; Loebel A; Koblan KS
    Schizophr Bull; 2018 Apr; 44(3):593-602. PubMed ID: 28981857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of parental bonding is associated with symptom severity and functioning among individuals at ultra-high risk for psychosis.
    Peh OH; Rapisarda A; Lee J
    Schizophr Res; 2020 Jan; 215():204-210. PubMed ID: 31699626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.